DE3678659D1 - Verminderung von dysfunktion in der angioplastik. - Google Patents

Verminderung von dysfunktion in der angioplastik.

Info

Publication number: DE3678659D1
Authority: DE; Germany
Prior art keywords: angioplastics; dysfunction; reduction
Prior art date: 1985-10-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE8686113836T

Other languages

English (en)

Inventor

William Elson Dr Shell

Jackie R Dr See

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SEE SHELL BIOTECHNOLOGY Inc

Original Assignee

SEE SHELL BIOTECHNOLOGY Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-04

Filing date

1986-10-06

Publication date

1991-05-16

1986-10-06 Application filed by SEE SHELL BIOTECHNOLOGY Inc filed Critical SEE SHELL BIOTECHNOLOGY Inc

1991-05-16 Application granted granted Critical

1991-05-16 Publication of DE3678659D1 publication Critical patent/DE3678659D1/de

2006-10-07 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE8686113836T 1985-10-04 1986-10-06 Verminderung von dysfunktion in der angioplastik. Expired - Fee Related DE3678659D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US78416085A	1985-10-04	1985-10-04
US06/848,233 US4820732A (en)	1985-10-04	1986-04-04	Method and compositions for reducing dysfunction in angioplasty procedures

Publications (1)

Publication Number	Publication Date
DE3678659D1 true DE3678659D1 (de)	1991-05-16

Family

ID=27120235

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8686113836T Expired - Fee Related DE3678659D1 (de)	1985-10-04	1986-10-06	Verminderung von dysfunktion in der angioplastik.

Country Status (6)

Country	Link
US (1)	US4820732A (de)
EP (1)	EP0217419B1 (de)
CA (1)	CA1287299C (de)
DE (1)	DE3678659D1 (de)
ES (1)	ES2036517T3 (de)
GR (1)	GR3002279T3 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5925375A (en) *	1987-05-22	1999-07-20	The Liposome Company, Inc.	Therapeutic use of multilamellar liposomal prostaglandin formulations
US5811118A (en) *	1987-05-22	1998-09-22	The Liposome Company, Inc.	Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
GB8814438D0 (en) *	1988-06-17	1988-07-20	Wellcome Found	Compounds for use in medicine
PT90888B (pt) *	1988-06-17	1994-12-30	Wellcome Found	Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas
JPH0669966B2 (ja) *	1989-07-05	1994-09-07	株式会社ミドリ十字	血管造影補助剤
US5882678A (en) *	1990-01-12	1999-03-16	The Liposome Co, Inc.	Interdigitation-fusion liposomes containing arachidonic acid metabolites
US5166143A (en) *	1990-05-31	1992-11-24	E. R. Squibb & Sons, Inc.	Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
US5990096A (en) *	1990-09-18	1999-11-23	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
US5824658A (en) *	1990-09-18	1998-10-20	Hyal Pharmaceutical Corporation	Topical composition containing hyaluronic acid and NSAIDS
US5910489A (en) *	1990-09-18	1999-06-08	Hyal Pharmaceutical Corporation	Topical composition containing hyaluronic acid and NSAIDS
CA2061703C (en) *	1992-02-20	2002-07-02	Rudolf E. Falk	Formulations containing hyaluronic acid
US5171217A (en) *	1991-02-28	1992-12-15	Indiana University Foundation	Method for delivery of smooth muscle cell inhibitors
ES2128343T3 (es) *	1991-05-07	1999-05-16	Liposome Co Inc	Formulaciones de prostaglandina liposomica.
US5990095A (en)	1991-07-03	1999-11-23	Hyal Pharmaceutical Corporation	Use of hyaluronic acid and forms to prevent arterial restenosis
US5977088A (en) *	1991-07-03	1999-11-02	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
DE4135193C1 (de) *	1991-10-22	1993-03-11	Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US6218373B1 (en)	1992-02-20	2001-04-17	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
US5767106A (en) *	1992-02-21	1998-06-16	Hyal Pharmaceutical Corporation	Treatment of disease and conditions associated with macrophage infiltration
US5840328A (en) *	1994-01-11	1998-11-24	The Liposome Company, Inc.	Treatment using arachidonic acid metabolite and particulate formulations
US5718917A (en) *	1995-12-15	1998-02-17	Harvard Scientific Corporation	PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US6207185B1 (en)	1996-03-22	2001-03-27	Bio-Sphere Technology	Method for inducing a systemic immune response to an HIV antigen
US6117449A (en) *	1996-03-22	2000-09-12	Bio-Sphere Technology, Inc.	Method for inducing a systemic immune response to a hepatitis antigen
US6015576A (en) *	1997-08-29	2000-01-18	Bio-Sphere Technology, Inc.	Method for inducing a systemic immune response to an antigen
US20070191320A1 (en) *	1998-12-10	2007-08-16	Nexmed Holdings, Inc.	Methods of treatment for female sexual arousal disorder
US6825234B2 (en)	1998-12-10	2004-11-30	Nexmed (Holdings) , Inc.	Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en)	1998-12-10	2002-11-26	Nexmed (Holdings), Inc.	Compositions and methods for amelioration of human female sexual dysfunction
AU2004227853A1 (en)	2003-04-02	2004-10-21	Nexmed (Holdings), Inc.	Prostaglandin compositions and their use for the treatment of vasospasm
JP2014510156A (ja)	2011-04-07	2014-04-24	ネクスメッドホールディングス，インコーポレイテッド	レイノー病を治療する方法および組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3966962A (en) *	1975-03-27	1976-06-29	The Upjohn Company	Triacetin solutions of PGE-type compounds
US4103026A (en) *	1976-08-23	1978-07-25	Carlson Lars A	Treatment of peripheral vascular disease by non-intraarterial administration of prostaglandin E1
US4680171A (en) *	1985-03-15	1987-07-14	William Shell	Visualization of a bloodstream circulation with biodegradable microspheres

1986
- 1986-04-04 US US06/848,233 patent/US4820732A/en not_active Expired - Lifetime
- 1986-09-30 CA CA000519375A patent/CA1287299C/en not_active Expired - Lifetime
- 1986-10-06 DE DE8686113836T patent/DE3678659D1/de not_active Expired - Fee Related
- 1986-10-06 ES ES198686113836T patent/ES2036517T3/es not_active Expired - Lifetime
- 1986-10-06 EP EP86113836A patent/EP0217419B1/de not_active Expired - Lifetime
1991
- 1991-07-09 GR GR91400982T patent/GR3002279T3/el unknown

Also Published As

Publication number	Publication date
EP0217419A3 (en)	1988-01-27
US4820732A (en)	1989-04-11
CA1287299C (en)	1991-08-06
GR3002279T3 (en)	1992-12-30
ES2036517T3 (es)	1993-06-01
EP0217419B1 (de)	1991-04-10
EP0217419A2 (de)	1987-04-08

Publication	Publication Date	Title
DE3678659D1 (de)	1991-05-16	Verminderung von dysfunktion in der angioplastik.
DE3684704D1 (de)	1992-05-07	Perfluorierung von aethern.
DE3687915D1 (de)	1993-04-15	Aenderung von gesichtsausdruecken in der kinematographie.
NO863185L (no)	1987-02-09	Benmorfogeniske midler.
ATE56234T1 (de)	1990-09-15	Bodenanker.
FI863074L (fi)	1987-02-01	Farmaceutiskt aktiva substanser i granulatform med foerdroejd frigivning.
FI882652L (fi)	1988-06-03	Pump.
DE3675716D1 (de)	1991-01-03	Ultrahochdruckwasserinjektor.
FI855026L (fi)	1986-10-25	Elektromekanisk oscillator foer dusch i en pappersmaskin.
DE3675777D1 (de)	1991-01-03	Einspritzvorrichtung.
FI864043A0 (fi)	1986-10-06	Vibrerande massageapparat.
DE3683032D1 (de)	1992-01-30	Summierung von adressenuebergangssignalen.
NO159616C (no)	1989-01-18	L smutter.
ATE112172T1 (de)	1994-10-15	Targetformer von antitumor-methyltrithioagenzien.
FI862956L (fi)	1987-01-19	Foerbaettringar i foerbraenningsmotorer med kompressor.
DE3677916D1 (de)	1991-04-11	Nachweis von retikulozyten.
FI863028A0 (fi)	1986-07-23	Avboejningskrets med en modulatorkrets i kopplingsform.
ATE53997T1 (de)	1990-07-15	N-substituierte diphenylpiperidine.
DE3673928D1 (de)	1990-10-11	Nachweis von retikulocyten.
KR870700539A (ko)	1987-12-29	앵커
DE3583063D1 (de)	1991-07-11	Elektrochemische reduktion von cyanpyridin-basen.
FI864714A0 (fi)	1986-11-19	Karbapenemderivat substituerade i 2-staellning med en kvaternaer heterotioalkyltiogrupp.
DE3775457D1 (de)	1992-02-06	Herabsetzung von sphaerolithen in polyamiden.
FI852876A0 (fi)	1985-07-24	Anordning foer undervattensarbete.
ATE62417T1 (de)	1991-04-15	Verminderung von dysfunktion in der angioplastik.

Legal Events

Date	Code	Title	Description
1992-05-14	8364	No opposition during term of opposition
2002-11-07	8339	Ceased/non-payment of the annual fee